Back
Mersana Therapeutics Quote, Financials, Valuation and Earnings
Your bank account could be compromised
Follow these three simple steps to protect your savings now.
Sell
17
MRSN
Mersana Therapeutics
Last Price:
2.10
Seasonality Move:
-30.99%
7 Day Trial
ALL ACCESS PASS
$
7
Unique Tesla Strategy Turned $1,000 into $9,770 in 20 Trading Days
Click here for detailsMersana Therapeutics Price Quote
$2.10
+0.01 (+2.94%)
(Updated: July 13, 2024 at 6:03 AM ET)
Mersana Therapeutics Key Stats
Sell
17
Mersana Therapeutics (MRSN)
is a Sell
Day range:
$2.02 - $2.16
52-week range:
$0.80 - $6.28
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
6.52
P/B ratio:
9.14%
Volume:
708K
Avg. volume:
1.4M
1-year change:
-44.85%
Market cap:
$255.7M
Revenue:
$36.9M
EPS:
$-1.14
How Much Does Mersana Therapeutics Make?
-
How Much Are Mersana Therapeutics's Sales Annually?
MRSN Revenues are $36.9M -
How Much Profit Does Mersana Therapeutics's Make A Year?
MRSN net income is -$171.7M
Is Mersana Therapeutics Growing As A Company?
-
What Is Mersana Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.18% -
What Is Mersana Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Mersana Therapeutics Stock Price Performance
-
Did Mersana Therapeutics Stock Go Up Last Month?
Mersana Therapeutics share price went down by -8.13% last month -
Did MRSN's Share Price Rise Over The Last Year?
MRSN share price fell by -44.85% over the past 1 year
What Is Mersana Therapeutics 52-Week High & Low?
-
What Is Mersana Therapeutics’s 52-Week High Share Price?
Mersana Therapeutics has traded as high as $6.28 over the past 52 weeks -
What Is Mersana Therapeutics’s 52-Week Low Share Price?
Mersana Therapeutics has traded as low as $0.80 over the past 52 weeks
Mersana Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Mersana Therapeutics?
-
How Much Debt Does Mersana Therapeutics Have?
Total long term debt quarterly is $25.3M -
How Much Cash Does Mersana Therapeutics Have?
Cash and short term investments quarterly total is $183.1M -
What Is Mersana Therapeutics’s Book Value Per Share?
Book value per share is 0.23
Is Mersana Therapeutics Cash Flow Positive?
-
What Is MRSN Cash Flow From Operations?
Cash flow from operations (TTM) is -$172.5M -
What Is Mersana Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $79M -
What Is Mersana Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $45.9M
Mersana Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
MRSN return on invested capital is -169.81% -
What Is Mersana Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -52.07% -
What Is MRSN Return On Equity?
ROE is a measure of profitability and is -248.57%
Mersana Therapeutics Earnings Date & Stock Price
-
What Is Mersana Therapeutics's Stock Price Today?
A single share of MRSN can be purchased today for 2.09 -
What Is Mersana Therapeutics’s Stock Symbol?
Mersana Therapeutics trades on the nasdaq under the ticker symbol: MRSN -
When Is Mersana Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Mersana Therapeutics is scheduled on August 9, 2024 -
When Is MRSN's next ex-dividend date?
Mersana Therapeutics's next ex-dividend date is July 13, 2024 -
How To Buy Mersana Therapeutics Stock?
You can buy Mersana Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Mersana Therapeutics Competitors
-
Who Are Mersana Therapeutics's Competitors?
Below is a list of companies who compete with Mersana Therapeutics or are related in some way:
Mersana Therapeutics Dividend Yield
Data Unavailable
Mersana Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 12.97% |
| Revenue: | 18.5% | 11.54% |
Analyst Recommendations
| Buy Recommendations: | 7 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 6.38 |
| Upside from Last Price: | 205.02% |